IL-23 has been demonstrated to be abnormally expressed in autoimmunity, including Experimental autoimmune encephalomyelitis (EAE), collagen-induced arthritis, and inflammatory bowel disease [79]. This evidence concerns the gene IL37 and Autoimmunity.